Publications

  1. Beutler AS, Kulkarni AA, Kanwar R, Klein CJ, Therneau TM, Qin R, Banck MS, Boora GK, Ruddy KJ, Wu Y, Smalley RL, Cunningham JM, Le-Lindqwister NA, Beyerlein P, Schroth GP, Windebank AJ, Zuchner S, Loprinzi CL. Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy. Ann Neurol. 2014 Nov; 76(5):727-37. Epub 2014 Sep 17.
    View PubMed
  2. Loprinzi CL, Qin R, Grothey A. Reply to C.d. Atkins and a. Avan et Al. J Clin Oncol. 2014 Oct 10; 32(29):3342-3. Epub 2014 Aug 18.
    View PubMed
  3. Cartin-Ceba R, Hubmayr RD, Qin R, Peters S, Determann RM, Schultz MJ, Gajic O. Predictive value of plasma biomarkers for mortality and organ failure development in patients with acute respiratory distress syndrome. J Crit Care. 2014 Sep 06.
    View PubMed
  4. Leal AD, Qin R, Atherton PJ, Haluska P, Behrens RJ, Tiber CH, Watanaboonyakhet P, Weiss M, Adams PT, Dockter TJ, Loprinzi CL, Alliance for Clinical Trials in Oncology. North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study. Cancer. 2014 Jun 15; 120(12):1890-7. Epub 2014 Mar 11.
    View PubMed
  5. Leenstra JL, Miller RC, Qin R, Martenson JA, Dornfeld KJ, Bearden JD, Puri DR, Stella PJ, Mazurczak MA, Klish MD, Novotny PJ, Foote RL, Loprinzi CL. Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]). J Clin Oncol. 2014 May 20; 32(15):1571-7. Epub 2014 Apr 14.
    View PubMed
  6. Loprinzi CL, Qin R, Dakhil SR, Fehrenbacher L, Flynn KA, Atherton P, Seisler D, Qamar R, Lewis GC, Grothey A. Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). J Clin Oncol. 2014 Apr 1; 32(10):997-1005. Epub 2013 Dec 02.
    View PubMed
  7. Kadakia KC, Leal AD, Seisler DK, Qin R, Fee-Schroeder KC, Grendahl DC, Sorgatz KM, Loprinzi CL. Antiemetic prescribing practices using a computerized physician order entry system. Support Care Cancer. 2014 Jan; 22(1):217-23. Epub 2013 Sep 13.
    View PubMed
  8. Pili R, Qin R, Flynn PJ, Picus J, Millward M, Ho WM, Pitot H, Tan W, Miles KM, Erlichman C, Vaishampayan U. A phase II safety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancer. Clin Genitourin Cancer. 2013 Dec; 11(4):477-83. Epub 2013 Jul 26.
    View PubMed
  9. Lavoie Smith EM, Barton DL, Qin R, Steen PD, Aaronson NK, Loprinzi CL. Assessing patient-reported peripheral neuropathy: the reliability and validity of the european organization for research and treatment of cancer qlq-cipn20 questionnaire. Qual Life Res. 2013 Dec; 22(10):2787-99.
  10. Kumar SK, Jett J, Marks R, Richardson R, Quevedo F, Moynihan T, Croghan G, Markovic SN, Bible KC, Qin R, Tan A, Molina J, Kaufmann SH, Erlichman C, Adjei AA. Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies. Invest New Drugs. 2013 Oct; 31(5):1201-6. Epub 2013 Jul 26.
    View PubMed
  11. Schenk E, Hendrickson AE, Northfelt D, Toft DO, Ames MM, Menefee M, Satele D, Qin R, Erlichman C. Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies. Invest New Drugs. 2013 Oct; 31(5):1251-6. Epub 2013 Mar 31.
    View PubMed
  12. Jones G, Arthurs B, Kaya H, Macdonald K, Qin R, Fairbanks RK, Lamoreaux WT, Jawed I, Tward JD, Martincic D, Shivnani AT, Lee CM. Overall survival analysis of adjuvant radiation versus observation in stage I testicular seminoma: a surveillance, epidemiology, and end results (SEER) analysis. Am J Clin Oncol. 2013 Oct; 36(5):500-4.
    View PubMed
  13. Ezzalfani M, Zohar S, Qin R, Mandrekar SJ, Deley MC. Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicities. Stat Med. 2013 Jul 20; 32(16):2728-46. Epub 2013 Jan 21.
    View PubMed
  14. Yang HJ, Qin R, Katusic S, Juhn YJ. Population-based study on association between birth weight and risk of asthma: a propensity score approach. Ann Allergy Asthma Immunol. 2013 Jan; 110(1):18-23. Epub 2012 Nov 10.
    View PubMed
  15. Clark K, Sharma D, Qin R, Jiang G, Chute CG, Tao C. Ontology-based temporal analysis for medical device adverse event- A use case study on Late Stent Thrombosis. CEUR Workshop Proceedings. 2013; 1114.
  16. Qin R, Kohli M. Pharmacogenetics- and pharmacogenomics-based rational clinical trial designs in oncology. Pers. Med. 2013; 10(8):859-69.
  17. Trujillo MA, Oneal MJ, McDonough S, Qin R, Morris JC. A steep radioiodine dose response scalable to humans in sodium-iodide symporter (NIS)-mediated radiovirotherapy for prostate cancer. Cancer Gene Ther. 2012 Dec; 19(12):839-44. Epub 2012 Oct 05.
    View PubMed
  18. Albuquerque FN, Somers VK, Blume G, Miranda W, Korenfeld Y, Calvin AD, Qin R, Lopez-Jimenez F. Usefulness of epicardial adipose tissue as predictor of cardiovascular events in patients with coronary artery disease. Am J Cardiol. 2012 Oct 15; 110(8):1100-5. Epub 2012 Jul 03.
    View PubMed
  19. Bryce AH, Rao R, Sarkaria J, Reid JM, Qi Y, Qin R, James CD, Jenkins RB, Boni J, Erlichman C, Haluska P. Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors. Invest New Drugs. 2012 Oct; 30(5):1934-41. Epub 2011 Sep 01.
    View PubMed
  20. Huebner M, Kendrick M, Reid-Lombardo KM, Que F, Therneau T, Qin R, Donohue J, Nagorney D, Farnell M, Sarr M. Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma. J Gastrointest Surg. 2012 May; 16(5):920-6. Epub 2012 Mar 16.
    View PubMed
  21. Kohli M, Riska SM, Mahoney DW, Chai HS, Hillman DW, Rider DN, Costello BA, Qin R, Lamba J, Sahasrabudhe DM, Cerhan JR. Germline predictors of androgen deprivation therapy response in advanced prostate cancer. Mayo Clin Proc. 2012 Mar; 87(3):240-6.
    View PubMed
  22. Wolf SL, Barton DL, Qin R, Wos EJ, Sloan JA, Liu H, Aaronson NK, Satele DV, Mattar BI, Green NB, Loprinzi CL. The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA. Support Care Cancer. 2012 Mar; 20(3):625-32. Epub 2011 Apr 12.
    View PubMed
  23. Pruthi S, Qin R, Terstreip SA, Liu H, Loprinzi CL, Shah TR, Tucker KF, Dakhil SR, Bury MJ, Carolla RL, Steen PD, Vuky J, Barton DL. A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7. Menopause. 2012 Jan; 19(1):48-53.
    View PubMed
  24. Jatoi A, Nieva JJ, Qin R, Loprinzi CL, Wos EJ, Novotny PJ, Moore DF Jr, Mowat RB, Bechar N, Pajon ER Jr, Hartmann LC. A pilot study of long-acting octreotide for symptomatic malignant ascites. Oncology. 2012; 82(6):315-20. Epub 2012 May 10.
    View PubMed
  25. Kohli M, Qin R, Jimenez R, Dehm SM. Biomarker-based targeting of the androgen-androgen receptor axis in advanced prostate cancer. Adv Urol. 2012; 2012:781459. Epub 2012 Aug 22.
    View PubMed
  26. Jones JM, Qin R, Bardia A, Linquist B, Wolf S, Loprinzi CL. Antiemetics for chemotherapy-induced nausea and vomiting occurring despite prophylactic antiemetic therapy. J Palliat Med. 2011 Jul; 14(7):810-4. Epub 2011 May 09.
    View PubMed
  27. Barton DL, Wos EJ, Qin R, Mattar BI, Green NB, Lanier KS, Bearden JD 3rd, Kugler JW, Hoff KL, Reddy PS, Rowland KM Jr, Riepl M, Christensen B, Loprinzi CL. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer. 2011 Jun; 19(6):833-41. Epub 2010 May 25.
    View PubMed
  28. Hubbard J, Erlichman C, Toft DO, Qin R, Stensgard BA, Felten S, Ten Eyck C, Batzel G, Ivy SP, Haluska P. Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors. Invest New Drugs. 2011 Jun; 29(3):473-80. Epub 2010 Jan 15
    View PubMed
  29. Wang JK, Holubar SD, Wolff BG, Follestad B, O'Byrne MM, Qin R. Risk factors for splenic injury during colectomy: a matched case-control study. World J Surg. 2011 May; 35(5):1123-9.
    View PubMed
  30. Reid JM, Walden CA, Qin R, Ziegler KL, Haslam JL, Rajewski RA, Warndahl R, Fitting CL, Boring D, Szabo E, Crowell J, Perloff M, Jong L, Bauer BA, Mandrekar SJ, Ames MM, Limburg PJ, Cancer Prevention Network. Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668. Cancer Prev Res (Phila). 2011 Mar; 4(3):347-53.
    View PubMed
  31. Titler MG, Shever LL, Kanak MF, Picone DM, Qin R. Factors associated with falls during hospitalization in an older adult population. Res Theory Nurs Pract. 2011; 25(2):127-48.
    View PubMed
  32. Wolf SL, Qin R, Menon SP, Rowland KM Jr, Thomas S, Delaune R, Christian D, Pajon ER Jr, Satele DV, Berenberg JL, Loprinzi CL, North Central Cancer Treatment Group Study N05C5. Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5. J Clin Oncol. 2010 Dec 10; 28(35):5182-7. Epub 2010 Nov 8
    View PubMed
  33. You YN, Wolff BG, Boardman LA, Riegert-Johnson DL, Qin R. Peutz-Jeghers syndrome: a study of long-term surgical morbidity and causes of mortality. Fam Cancer. 2010 Dec; 9(4):609-16.
    View PubMed
  34. Trujillo MA, Oneal MJ, McDonough S, Qin R, Morris JC. A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer. Gene Ther. 2010 Nov; 17(11):1325-32. Epub 2010 Apr 29.
    View PubMed
  35. Mandrekar SJ, Qin R, Sargent DJ. Model-based phase I designs incorporating toxicity and efficacy for single and dual agent drug combinations: methods and challenges. Stat Med. 2010 May 10; 29(10):1077-83.
    View PubMed
  36. Juhn YJ, Qin R, Urm S, Katusic S, Vargas-Chanes D. The influence of neighborhood environment on the incidence of childhood asthma: a propensity score approach. J Allergy Clin Immunol. 2010 Apr; 125(4):838-843.e2. Epub 2010 Mar 17.
    View PubMed
  37. Vuk-Pavlovic S, Bulur PA, Lin Y, Qin R, Szumlanski CL, Zhao X, Dietz AB. Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer. Prostate. 2010 Mar 1; 70(4):443-55.
    View PubMed
  38. Loprinzi CL, Qin R, Balcueva EP, Flynn KA, Rowland KM Jr, Graham DL, Erwin NK, Dakhil SR, Jurgens DJ, Burger KN. Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. J Clin Oncol. 2010 Feb 1; 28(4):641-7. Epub 2009 Nov 09.
    View PubMed
  39. Kerr P, Shever L, Titler MG, Qin R, Kim T, Picone DM. The unique contribution of the nursing intervention pain management on length of stay in older patients undergoing hip procedures. Appl Nurs Res. 2010 Feb; 23(1):36-44. Epub 2009 Jan 15.
    View PubMed
  40. Malireddy K, Larson DW, Sandborn WJ, Loftus EV, Faubion WA, Pardi DS, Qin R, Gullerud RE, Cima RR, Wolff B, Dozois EJ. Recurrence and impact of postoperative prophylaxis in laparoscopically treated primary ileocolic Crohn disease. Arch Surg. 2010 Jan; 145(1):42-7.
    View PubMed
  41. Holubar SD, Wang JK, Wolff BG, Nagorney DM, Dozois EJ, Cima RR, O'Byrne MM, Qin R, Larson DW. Splenic salvage after intraoperative splenic injury during colectomy. Arch Surg. 2009 Nov; 144(11):1040-5.
    View PubMed
  42. Barton JG, Bois JP, Sarr MG, Wood CM, Qin R, Thomsen KM, Kendrick ML, Farnell MB. Predictive and prognostic value of CA 19-9 in resected pancreatic adenocarcinoma. J Gastrointest Surg. 2009 Nov; 13(11):2050-8. Epub 2009 Sep 09.
    View PubMed
  43. Schoenleber SJ, Schnelldorfer T, Wood CM, Qin R, Sarr MG, Donohue JH. Factors influencing lymph node recovery from the operative specimen after gastrectomy for gastric adenocarcinoma. J Gastrointest Surg. 2009 Jul; 13(7):1233-7. Epub 2009 Apr 15.
    View PubMed
  44. Tsikitis VL, Larson DL, Wolff BG, Kennedy G, Diehl N, Qin R, Dozois EJ, Cima RR. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved. J Am Coll Surg. 2009 Jan; 208(1):42-7.
    View PubMed
  45. Qin R, Titler MG, Shever LL, Kim T. Estimating effects of nursing intervention via propensity score analysis. Nurs Res. 2008 Nov-Dec; 57(6):444-52.
    View PubMed
  46. Schnelldorfer T, Sarr MG, Nagorney DM, Zhang L, Smyrk TC, Qin R, Chari ST, Farnell MB. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg. 2008 Jul; 143(7):639-46; discussion 646.
    View PubMed
  47. Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, Gullerud RE, Donohue JH, Nagorney DM, Farnell MB. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg. 2008 Mar; 247(3):456-62.
    View PubMed
  48. Picone DM, Titler MG, Dochterman J, Shever L, Kim T, Abramowitz P, Kanak M, Qin R. Predictors of medication errors among elderly hospitalized patients. Am J Med Qual. 2008 Mar-Apr; 23(2):115-27. Epub 2008 Feb 27.
    View PubMed
  49. Shever L, Titler M, Herr P, Qin R, Kim T, Picone D. The effect of high Nursing surveillance on hospital cost. J Nurs Scholarship. 2008; 40:161-169.